Spotlight Pathology develops AI-powered decision support tools that integrate with existing digital pathology systems to enhance the diagnosis of blood cancers. The platform addresses the critical shortage of pathologists and increasing diagnostic workloads by minimizing turnaround times and improving the objectivity of tissue biopsy assessments.
Funding
$490K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The increasing global incidence of blood cancers, coupled with a shortage of trained pathologists, creates a bottleneck in diagnostic services. This shortage leads to delays in accurate assessment of tissue biopsy samples, impacting patient care and treatment timelines. The rising complexity of diagnoses and personalized therapy further exacerbates the workload challenges faced by pathologists.
Solution
Spotlight Pathology offers AI-powered decision support tools designed to integrate with existing digital pathology infrastructure, streamlining the diagnosis of blood cancers. The platform leverages machine learning algorithms to minimize diagnostic turnaround times, increase pathologist productivity through automated cell counting, and improve the objectivity of tissue biopsy assessments. By automating sample classification and triage, the solution enables faster diagnostic turnaround for complex cases and supports better targeting of treatments to patients. The AI-based tools increase the capacity of pathology departments to meet the rising demand for their services, alleviating staff burnout and increasing throughput.
Target Audience
The primary target audience includes hospital pathology departments, pathologists, and healthcare providers specializing in blood cancer diagnosis and treatment.
Features
- AI-powered diagnostic support for blood cancer diagnosis
- Integration with existing digital pathology systems, eliminating the need for additional hardware
- Automated cell counting to increase pathologist productivity
- Sample classification and triage to speed up diagnostic turnaround
- Enhanced objectivity in diagnosis to support better treatment targeting
- Algorithms for cancer detection, cell type differentiation, and automated cell counts
- Spatial analysis capabilities for quantifying heterogeneity
- Tools for discovering novel molecular biomarkers for patient risk stratification
- Ability to combine insights from multi-modal datasets